IL-22 produced by cancer-associated fibroblasts promotes gastric cancer cell invasion via STAT3 and ERK signaling

High Expression of Interleukin-22 and Its Receptor Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma

(2013) Zhang Wen et al.   ANNALS OF SURGICAL ONCOLOGY

IL-22, not simply a Th17 cytokine

(2013) Sascha Rutz et al.   IMMUNOLOGICAL REVIEWS

Interleukin-22 Is Frequently Expressed in Small- and Large-Cell Lung Cancer and Promotes Growth in Chemotherapy-Resistant Cancer Cells

(2013) Sebastian Kobold et al.   Journal of Thoracic Oncology

Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression

(2011) Paolo Cirri et al.   CANCER AND METASTASIS REVIEWS

Stat3 and MMP7 Contribute to Pancreatic Ductal Adenocarcinoma Initiation and Progression

(2011) Akihisa Fukuda et al.   CANCER CELL

Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3

(2011) Runqiu Jiang et al.   HEPATOLOGY

Recent advances in IL-22 biology

(2011) L. A. Zenewicz et al.   INTERNATIONAL IMMUNOLOGY

DMBT1 is a novel gene induced by IL-22 in ulcerative colitis

(2010) Hirokazu Fukui et al.   INFLAMMATORY BOWEL DISEASES

Involvement of the IL-22/REG Iα axis in ulcerative colitis

(2010) Akira Sekikawa et al.   LABORATORY INVESTIGATION

Dexamethasone suppresses interleukin-22 associated with bacterial infectionin vitroandin vivo

(2009) E. Ziesché et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Cancer associated fibroblasts (CAFs) in tumor microenvironment

(2009) Fei Xing   Frontiers in Bioscience-Landmark

Antiapoptotic Activity of Autocrine Interleukin-22 and Therapeutic Effects of Interleukin-22-Small Interfering RNA on Human Lung Cancer Xenografts

(2008) W. Zhang et al.   CLINICAL CANCER RESEARCH